looking at recent 4c reports that the business obviously has a product the market wants. The only issue seems to be with staff and manufacture costs it seems to cost about same amount to make as it sells for? I wonder if they are able to claim r and d refunds like many in the medical area.
If they can show consistent cash flow positive trading for a few quarters the share price should be well north of current levels. Hopefully they have good payment terms on the new shots so income generated appears in next 4c.
Ann: FOD gathers momentum in Australian Health & Wellness Market, page-110
-
- There are more pages in this discussion • 163 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OJC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $48.88M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 15.5¢ | $56.58K | 357.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40766 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 110612 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| OJC (ASX) Chart |